Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors

Standard

Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors. / Frisch, Sabine; Libuschewski, Hanna; Peters, Sarah; Gerß, Joachim; von Hoff, Katja; Kortmann, Rolf-Dieter; Nemes, Karolina; Rutkowski, Stefan; Hasselblatt, Martin; Pietsch, Torsten; Frühwald, Michael C; Timmermann, Beate.

In: INT J RADIAT ONCOL, Vol. 119, No. 4, 15.07.2024, p. 1147-1157.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Frisch, S, Libuschewski, H, Peters, S, Gerß, J, von Hoff, K, Kortmann, R-D, Nemes, K, Rutkowski, S, Hasselblatt, M, Pietsch, T, Frühwald, MC & Timmermann, B 2024, 'Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors', INT J RADIAT ONCOL, vol. 119, no. 4, pp. 1147-1157. https://doi.org/10.1016/j.ijrobp.2024.01.200

APA

Frisch, S., Libuschewski, H., Peters, S., Gerß, J., von Hoff, K., Kortmann, R-D., Nemes, K., Rutkowski, S., Hasselblatt, M., Pietsch, T., Frühwald, M. C., & Timmermann, B. (2024). Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors. INT J RADIAT ONCOL, 119(4), 1147-1157. https://doi.org/10.1016/j.ijrobp.2024.01.200

Vancouver

Bibtex

@article{a4c60e7a792f4b5289a34e9d81558b2b,
title = "Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors",
abstract = "PURPOSE: Atypical teratoid/rhabdoid tumor (AT/RT) is a rare malignancy of the central nervous system in young children with a dismal prognosis. Prognostic markers have been extensively investigated but have not been validated. The role of radiation therapy (RT) remains controversial. We evaluated the impact of RT as part of multimodality treatment by analyzing data of a European AT/RT cohort.METHODS AND MATERIALS: We retrospectively analyzed data of the European Registry for Rhabdoid Tumors and its precursors. Primary endpoints were progression-free survival (PFS) and overall survival (OS). Potential impact of prognostic factors was analyzed using univariable and multivariable Cox regression analyses with RT as a time-dependent factor.RESULTS: Data of 186 children (118 male, 68 female) treated from 1990 to 2016 were evaluable. The median age at diagnosis was 1.57 years (range, 0.01-26.70 years); 47% (87/186) of the patients were under the age of 18 months. Sixty-nine percent (128/186) received RT (focal RT, n = 93; craniospinal treatment with local boost, n = 34; spinal irradiation, n = 1). The median follow-up duration of the entire cohort was 1.73 years (range, 0.06-20.11 years). The estimated PFS and OS rates were 48% (95% CI, 41%-55%) and 72% (95% CI, 65%-78%) at 1 year and 33% (95% CI, 26%-40%) and 49% (95% CI, 41%-56%) at 2 years, respectively. On multivariable analysis, RT was an independent significant prognostic factor for PFS (hazard ratio, 0.45; 95% CI, 0.27-0.75; P = .002) and OS (hazard ratio, 0.54; 95% CI, 0.32-0.93; P = .025).CONCLUSIONS: This analysis confirms the relevance of local therapies. RT was an independent prognostic factor for outcomes in children experiencing AT/RT. However, long-term sequelae have to be carefully evaluated and considered given the young age at time of RT.",
keywords = "Humans, Rhabdoid Tumor/radiotherapy, Male, Female, Child, Preschool, Infant, Teratoma/radiotherapy, Retrospective Studies, Child, Progression-Free Survival, Adolescent, Europe, Young Adult, Adult, Infant, Newborn, Prognosis, Registries, Proportional Hazards Models",
author = "Sabine Frisch and Hanna Libuschewski and Sarah Peters and Joachim Ger{\ss} and {von Hoff}, Katja and Rolf-Dieter Kortmann and Karolina Nemes and Stefan Rutkowski and Martin Hasselblatt and Torsten Pietsch and Fr{\"u}hwald, {Michael C} and Beate Timmermann",
note = "Copyright {\textcopyright} 2024 The Authors. Published by Elsevier Inc. All rights reserved.",
year = "2024",
month = jul,
day = "15",
doi = "10.1016/j.ijrobp.2024.01.200",
language = "English",
volume = "119",
pages = "1147--1157",
journal = "INT J RADIAT ONCOL",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Radiation Therapy Plays an Important Role in the Treatment of Atypical Teratoid/Rhabdoid Tumors: Analysis of the EU-RHAB Cohorts and Their Precursors

AU - Frisch, Sabine

AU - Libuschewski, Hanna

AU - Peters, Sarah

AU - Gerß, Joachim

AU - von Hoff, Katja

AU - Kortmann, Rolf-Dieter

AU - Nemes, Karolina

AU - Rutkowski, Stefan

AU - Hasselblatt, Martin

AU - Pietsch, Torsten

AU - Frühwald, Michael C

AU - Timmermann, Beate

N1 - Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

PY - 2024/7/15

Y1 - 2024/7/15

N2 - PURPOSE: Atypical teratoid/rhabdoid tumor (AT/RT) is a rare malignancy of the central nervous system in young children with a dismal prognosis. Prognostic markers have been extensively investigated but have not been validated. The role of radiation therapy (RT) remains controversial. We evaluated the impact of RT as part of multimodality treatment by analyzing data of a European AT/RT cohort.METHODS AND MATERIALS: We retrospectively analyzed data of the European Registry for Rhabdoid Tumors and its precursors. Primary endpoints were progression-free survival (PFS) and overall survival (OS). Potential impact of prognostic factors was analyzed using univariable and multivariable Cox regression analyses with RT as a time-dependent factor.RESULTS: Data of 186 children (118 male, 68 female) treated from 1990 to 2016 were evaluable. The median age at diagnosis was 1.57 years (range, 0.01-26.70 years); 47% (87/186) of the patients were under the age of 18 months. Sixty-nine percent (128/186) received RT (focal RT, n = 93; craniospinal treatment with local boost, n = 34; spinal irradiation, n = 1). The median follow-up duration of the entire cohort was 1.73 years (range, 0.06-20.11 years). The estimated PFS and OS rates were 48% (95% CI, 41%-55%) and 72% (95% CI, 65%-78%) at 1 year and 33% (95% CI, 26%-40%) and 49% (95% CI, 41%-56%) at 2 years, respectively. On multivariable analysis, RT was an independent significant prognostic factor for PFS (hazard ratio, 0.45; 95% CI, 0.27-0.75; P = .002) and OS (hazard ratio, 0.54; 95% CI, 0.32-0.93; P = .025).CONCLUSIONS: This analysis confirms the relevance of local therapies. RT was an independent prognostic factor for outcomes in children experiencing AT/RT. However, long-term sequelae have to be carefully evaluated and considered given the young age at time of RT.

AB - PURPOSE: Atypical teratoid/rhabdoid tumor (AT/RT) is a rare malignancy of the central nervous system in young children with a dismal prognosis. Prognostic markers have been extensively investigated but have not been validated. The role of radiation therapy (RT) remains controversial. We evaluated the impact of RT as part of multimodality treatment by analyzing data of a European AT/RT cohort.METHODS AND MATERIALS: We retrospectively analyzed data of the European Registry for Rhabdoid Tumors and its precursors. Primary endpoints were progression-free survival (PFS) and overall survival (OS). Potential impact of prognostic factors was analyzed using univariable and multivariable Cox regression analyses with RT as a time-dependent factor.RESULTS: Data of 186 children (118 male, 68 female) treated from 1990 to 2016 were evaluable. The median age at diagnosis was 1.57 years (range, 0.01-26.70 years); 47% (87/186) of the patients were under the age of 18 months. Sixty-nine percent (128/186) received RT (focal RT, n = 93; craniospinal treatment with local boost, n = 34; spinal irradiation, n = 1). The median follow-up duration of the entire cohort was 1.73 years (range, 0.06-20.11 years). The estimated PFS and OS rates were 48% (95% CI, 41%-55%) and 72% (95% CI, 65%-78%) at 1 year and 33% (95% CI, 26%-40%) and 49% (95% CI, 41%-56%) at 2 years, respectively. On multivariable analysis, RT was an independent significant prognostic factor for PFS (hazard ratio, 0.45; 95% CI, 0.27-0.75; P = .002) and OS (hazard ratio, 0.54; 95% CI, 0.32-0.93; P = .025).CONCLUSIONS: This analysis confirms the relevance of local therapies. RT was an independent prognostic factor for outcomes in children experiencing AT/RT. However, long-term sequelae have to be carefully evaluated and considered given the young age at time of RT.

KW - Humans

KW - Rhabdoid Tumor/radiotherapy

KW - Male

KW - Female

KW - Child, Preschool

KW - Infant

KW - Teratoma/radiotherapy

KW - Retrospective Studies

KW - Child

KW - Progression-Free Survival

KW - Adolescent

KW - Europe

KW - Young Adult

KW - Adult

KW - Infant, Newborn

KW - Prognosis

KW - Registries

KW - Proportional Hazards Models

U2 - 10.1016/j.ijrobp.2024.01.200

DO - 10.1016/j.ijrobp.2024.01.200

M3 - SCORING: Journal article

C2 - 38246248

VL - 119

SP - 1147

EP - 1157

JO - INT J RADIAT ONCOL

JF - INT J RADIAT ONCOL

SN - 0360-3016

IS - 4

ER -